Editor's key points † B-type natriuretic peptide (BNP) is a marker of left ventricular systolic dysfunction. † This study confirmed an association between elevated preoperative BNP and perioperative major adverse cardiac events. † The optimum cut-off value for identifying patients at risk of postoperative adverse outcomes remains unclear.
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Although various methods can stratify risk on a population basis, accurate individual assessment of cardiac risk after major surgery is difficult. Clinical assessment and ECG analysis are simple, low cost, and routinely available, but have little predictive value, 2 and cardiac scoring systems are notoriously inaccurate. 3 Other more specialized tests of cardiac structure and function which show promise, such as stress echocardiography, may not be widely available and have low positive predictive values. 4 Recently, the cardiac neurohormone, B-type natriuretic peptide (BNP), has emerged as a biological marker (biomarker) of cardiac mortality. BNP is synthesized predominantly within ventricular myocytes in response to cardiac wall stress. It is a sensitive marker of left ventricular systolic dysfunction 5 and is a useful tool in the investigation of patients with suspected heart failure. 6 7 Furthermore, BNP can predict major adverse cardiac events (MACE), defined as cardiac death and myocardial infarction, in acute coronary syndrome patients 8 and in heart failure patients. 9 We have previously shown that BNP is an independent predictor of perioperative cardiac events in patients undergoing major non-cardiac surgery, 10 11 and this observation has been confirmed by other groups. 12 -15 In order to test the long-term significance of preoperative BNP, we aimed to determine whether plasma BNP concentration also predicted long-term survival in patients undergoing major non-cardiac surgery.
Methods

Participants
A prospective single-centre observational cohort study of consecutive patients undergoing major non-cardiac surgery between January 2004 and August 2006 was performed. The initial 190 patients were analysed for short-term cardiac mortality and morbidity and these results have already been published. 10 11 The first seven patients were omitted from this study due to non-standardized sampling techniques. Emergency patients (operated within 24 h of an unplanned admission) were not included. This left 345 patients who were included in this study. All patients had standard preoperative assessment, including clinical history, laboratory blood tests, and a 12-lead ECG. Further cardiorespiratory investigations were carried out at the discretion of the operating team. Comorbidities were based on medical history and self-reporting. The Revised Cardiac Index (RCI) [a validated risk index that includes a history of ischaemic heart disease (IHD), heart failure, cerebrovascular disease, insulin therapy, renal impairment, and high-risk surgery] was calculated for each patient. 16 IHD was defined as a previous myocardial infarction, a positive exercise tolerance test, the use of nitrate therapy, or the presence of pathological Q-waves on ECG. Left ventricular failure (LVF) was considered present if the patient had a prior hospital admission with heart failure or left ventricular impairment on previous echocardiography. Cerebrovascular disease was defined as a previous cerebrovascular accident or transient ischaemic attack. The glomerular filtration rate (GFR) was estimated using the modification of diet in renal disease (MDRD) equation.
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Renal impairment was considered present, if the estimated GFR was ,60 ml min 21 . A patient was considered a smoker, if they were smoking at the time of admission for surgery. Hypertension was considered present, if the patient had previous medical documentation of hypertension and was currently taking antihypertensive medication. The presence of hyperlipidaemia and chronic obstructive pulmonary disease was extracted from the patient's primary care records and past medical history. The current medication was also recorded, in particular the prescription of antiplatelet agents, a statin, and b-blockers. An additional venous blood sample was obtained for plasma BNP the evening before surgery. This was collected in chilled EDTA and aprotinin (Trasylol; 50 IU ml 21 ), immediately centrifuged, and stored at 2258C. BNP concentrations were measured using a direct immunoradiometric assay (Shionoria BNP kit, Shinogi & Co., Osaka, Japan). 18 The minimum detectable quantity of BNP is 2 pg ml 21 . The within-assay and between-assay coefficients of variation are 5.3% and 5.9%, respectively. Batch sample analysis was performed during the study by a biochemist blinded to clinical detail. The longest sample storage period was 6 months. Postoperative screening for cardiac events was performed. This consisted of daily clinical assessment and serial ECGs and troponin I measurement on day 2, day 5, and 6 weeks after surgery. The first outpatient follow-up was performed at 6 weeks, and this was defined as the postoperative period. Patient follow-up was carried out until August 2008. All patients were followed-up for a minimum of 1 yr, either at outpatient follow-up, with the general practitioner (GP), or by direct patient contact. The primary outcomes were death and MACE within the postoperative period (6 weeks) and all-cause mortality during the follow-up period. Regional ethics committee approval was obtained and all patients gave written consent to the study after a verbal explanation and written information.
Statistical analysis
Statistical analysis was performed using SPSS (Version 15) statistical software package (SPSS, Chicago, IL, USA). A P-value of ,0.05 was considered significant. Comparison of interval data was performed using independent samples t-tests, Mann-Whitney test, and Kruskal-Wallis tests as appropriate. Categorical data were compared using the x 2 test. Performance of continuous variables was analysed used receiver operating characteristics (ROC) and the area under the curve (AUC) was calculated. Survival analysis was performed using the Kaplan -Meier curves, and comparisons were made using the log-rank statistic. Univariate analysis was performed using Cox's regression analysis. The risk of an event for individual variables was displayed as a hazard ratio (HR). Variables with a P-value of ,0.10 were further evaluated with a multivariate Cox analysis using a backward stepwise selection. Since the study population comprised both general and vascular surgical patients, a subgroup analysis by the type of surgical procedure was performed.
Results
Of the 345 patients recruited for the study, 217 (62.9%) were males and the mean population age was 68.4 (range 28-93) yr. IHD was present in 29.9% of patients, 42.0% were smokers, and 18.6% had a history of LVF (Table 1) . A total of 276 (80%) patients underwent a vascular procedure (aortic surgery 25.8%, lower limb bypass 29.8%, and amputation 25.2%) and 69 (20.0%) patients underwent a laparotomy. This reflected the work load of the operating unit, and to prevent selection bias, the results are presented for the entire cohort.
The perioperative (6 weeks) MACE rate was 13 There were 27 (7.8%) perioperative deaths (within 6 weeks) and 84 (24.3%) deaths within the subsequent follow-up period. The median follow-up period was 953 days (IQR 661-1216 days). For the entire cohort, the median (IQR) preoperative BNP concentration was higher in patients who died during follow-up than in those who did not [95 (37 -310) vs 29 (13-74.5) pg ml 21 , P,0.001].
Furthermore, analysis of the 318 patients who survived beyond the perioperative period showed that BNP was higher in those patients who died compared with those who survived [147 (44 -407) vs 32 (14-82.5) pg ml 21 ,
An ROC curve analysis was performed to identify the BNP concentration that best predicted long-term mortality (Fig. 1) . In all patients, a BNP concentration of 87.5 pg ml 21 had the best combined sensitivity (65.7%) and specificity (78.6%), and the AUC was 0.781 (95% CI 0.717 -0.845, P,0.001). The AUC for patients undergoing a vascular procedure (n¼276) was 0.792 (95% CI 0.724 -0.861, P,0.001), with the same BNP concentration providing the best sensitivity and specificity in this group (67.8% and 76.8%, respectively).
The mean survival of patients with a BNP.87.5 pg ml 21 compared with a BNP,87.5 pg ml 21 was 732 days (95% CI 613.6 -850.2) vs 1285 days (95% CI 1219.3-1350.0), P,0.001 (Fig. 2) . At the minimum follow-up point (1 yr postoperation), the mortality rate for patients with a BNP.87. group with IHD (769 vs 1269 days, P,0.001) and the group without IHD (700 vs 1289 days, P,0.001).
On univariate analyses, age, BNP.87.5 pg ml 21 , diabetes, hypertension, LVF, and reduced GFR were significant predictors of reduced survival ( 
Discussion
We have shown that preoperative BNP predicts long-term survival after major non-cardiac surgery, independent of other prognostic characteristics. Secondly, we found that the prognostic value of BNP was similar in both vascular and non-vascular surgical cohorts, and in the presence and absence of IHD. Our study extends the findings of other smaller cohort studies in this subject, which had shorter follow-up periods. Much effort has been spent in devising stratification systems to identify patients at higher risk of postoperative mortality. A point-of-care test that is easy to perform, cheap, and reliably informative has proved elusive. Recent interest in the predictive value of a preoperative BNP has been fuelled by a number of studies published in recent years that have shown BNP to predict long-term outcomes in nonsurgical patients with both stable cardiac disease and cardiac failure. 5 6 8 BNP has also been shown to predict postoperative MACE and therefore postoperative mortality. 11 12 Few studies have analysed the long-term efficacy of natriuretic peptides in the prediction of postoperative outcome. Cuthbertson and colleagues 19 studied the medium-term follow-up (median 654 days) of 204 patients undergoing major non-cardiac surgery and found preoperative BNP to be a significant independent predictor of mortality. Feringa and colleagues 20 measured N-terminal pro-BNP (NT-proBNP), the inactive precursor of BNP, before operation and found it to predict long-term mortality in 335 patients undergoing major vascular surgery. This study shows that an elevated preoperative BNP is associated with a reduced long-term survival, independent of other factors. These results appear, in this study, to be consistent in both vascular patients in addition to other patients groups undergoing major surgery.
Since consecutive patients were included in our study, there is considerable heterogeneity in patient characteristics. Thus, our patients had a broad range of concomitant health problems and the surgical problems involved acute illness and critical chronic disease, such as due to chronic progressive limb ischaemia. While the prognostic value of BNP may be greater in particular subgroups (and future studies could address this question), we suggest that the heterogeneity in our population may in fact make our results more transferable to ordinary clinical practice. Our follow-up data were obtained in three ways: by hospital clinicians, by GP contact, and by direct patient contact; however, since the endpoint was all-cause mortality, there is not a risk of bias in the assessment of outcomes.
We found that a BNP concentration of 87.5 pg ml 21 provided the best sensitivity and specificity for all-cause mortality. Previous studies have identified variable levels of BNP that provided the best combined sensitivity and specificity for perioperative MACE. Cuthbertson and colleagues 12 13 Preoperative risk stratification has become more important in recent years as the range of surgical options has increased, and older patients with greater comorbidty are being considered for surgical intervention. Alternatives to traditional surgery, such as minimally invasive surgery, endovascular intervention, and endoscopic procedures, have become commonplace, with a corresponding risk reduction for surgery. Improvements in intraoperative anaesthetic techniques and postoperative critical care in the highdependency setting may also contribute to reduced overall risk. These improvements have several beneficial consequences. First, since procedure-related risk is reduced, overall clinical outcomes are improved. Secondly, a broader range of higher-risk patients (e.g. increased comorbidity) may be considered for surgery when previously surgery would not have been performed. Thirdly, in patients who are identified to be at high risk of procedure-related complications, implementation of selected contemporary surgical and anaesthetic techniques could lead to individualized risk reduction. Since BNP predicts long-term prognosis, this information may be used to guide surgical management.
Conclusion
Our study shows that a simple blood test offers valuable additional information in the prediction of long-term mortality and should be considered in the routine preoperative cardiac risk assessment of patients undergoing major noncardiac surgery. Future studies should address the health economic implications of this inexpensive blood test which has the potential to be cost-effective.
